应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
02160 心通医疗-B
未开盘 07-22 16:08:56
0.800
-0.040
-4.76%
最高
0.840
最低
0.800
成交量
627.90万
今开
0.830
昨收
0.840
日振幅
4.76%
总市值
19.30亿
流通市值
19.30亿
总股本
24.13亿
成交额
512.62万
换手率
0.26%
流通股本
24.13亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
心通医疗-B:与科威医疗达成多项合作 1000 万贷款
和讯网 · 07-22 08:21
心通医疗-B:与科威医疗达成多项合作 1000 万贷款
心通医疗-B:上海微创心通与科威医疗订立2024年科威分销框架协议
新浪港股 · 07-22 07:54
心通医疗-B:上海微创心通与科威医疗订立2024年科威分销框架协议
心通医疗-B(02160):上海微创心通与科威医疗订立2024年科威分销框架协议
智通财经 · 07-19
心通医疗-B(02160):上海微创心通与科威医疗订立2024年科威分销框架协议
心通医疗-B(02160)下跌5.68%,报0.83元/股
金融界 · 07-19
心通医疗-B(02160)下跌5.68%,报0.83元/股
心通医疗-B盘中异动 股价大跌5.68%
自选股智能写手 · 07-19
心通医疗-B盘中异动 股价大跌5.68%
心通医疗-B(02160)股价下跌5.682%,现价港币$0.83
阿斯达克财经 · 07-19
心通医疗-B(02160)股价下跌5.682%,现价港币$0.83
心通医疗-B盘中异动 股价大涨5.95%报0.890港元
自选股智能写手 · 07-11
心通医疗-B盘中异动 股价大涨5.95%报0.890港元
心通医疗-B(02160)股价上升5.952%,现价港币$0.89
阿斯达克财经 · 07-11
心通医疗-B(02160)股价上升5.952%,现价港币$0.89
心通医疗-B07月08日主力资金流出67万元 连续3日减仓
自选股智能写手 · 07-08
心通医疗-B07月08日主力资金流出67万元 连续3日减仓
心通医疗-B07月05日遭主力抛售59万元 环比增加195.00%
自选股智能写手 · 07-05
心通医疗-B07月05日遭主力抛售59万元 环比增加195.00%
心通医疗预计今年上半年收入同比增长22%-28%
新京报网 · 07-05
心通医疗预计今年上半年收入同比增长22%-28%
港股异动 | 发盈喜,心通医疗-B一度涨超8% 日前曾创新低
格隆汇资讯 · 07-05
港股异动 | 发盈喜,心通医疗-B一度涨超8% 日前曾创新低
心通医疗-B早盘一度涨超8% 预计上半年收入同比增长逾22%
新浪港股 · 07-05
心通医疗-B早盘一度涨超8% 预计上半年收入同比增长逾22%
港股异动 | 心通医疗-B(02160)一度涨超8% 预计上半年收入同比增长逾22%
智通财经 · 07-05
港股异动 | 心通医疗-B(02160)一度涨超8% 预计上半年收入同比增长逾22%
心通医疗-B盘中异动 股价大涨5.95%
自选股智能写手 · 07-05
心通医疗-B盘中异动 股价大涨5.95%
【港股通】心通医疗(02160)料中期收入同比增长约22%至28%
金吾财讯 · 07-05
【港股通】心通医疗(02160)料中期收入同比增长约22%至28%
心通医疗-B预计中期收入约2.15亿至2.25亿元 同比增长约22%至28%
新浪港股 · 07-05
心通医疗-B预计中期收入约2.15亿至2.25亿元 同比增长约22%至28%
心通医疗(02160.HK)预告上半年收入增加22%-28%
阿斯达克财经 · 07-05
心通医疗(02160.HK)预告上半年收入增加22%-28%
心通医疗-B:上半年收入预计增长22%至28%,达215至225百万元
和讯网 · 07-04
心通医疗-B:上半年收入预计增长22%至28%,达215至225百万元
心通医疗-B:预计2024年上半年收入达215百万元至225百万元人民币,同比增长22%至28%
金融界港股 · 07-04
心通医疗-B:预计2024年上半年收入达215百万元至225百万元人民币,同比增长22%至28%
加载更多
公司概况
公司名称:
心通医疗-B
所属市场:
SEHK
上市日期:
--
主营业务:
微创心通医疗科技有限公司是一家主要从事医疗器械行业的中国投资控股公司。该公司主要从事心脏瓣膜疾病领域经导管及手术解决方案的研发和商业化。该公司主要产品包括第一代经导管主动脉瓣植入(TAVI)产 品“VitaFlow”和第二代TAVI产品“VitaFlow II”。该公司主要于国内市场开展业务。
发行价格:
--
{"stockData":{"symbol":"02160","market":"HK","secType":"STK","nameCN":"心通医疗-B","latestPrice":0.8,"timestamp":1721635736028,"preClose":0.84,"halted":0,"volume":6279012,"delay":0,"floatShares":2412592839,"shares":2412592839,"eps":-0.21357986,"marketStatus":"未开盘","marketStatusCode":0,"change":-0.04,"latestTime":"07-22 16:08:56","open":0.83,"high":0.84,"low":0.8,"amount":5126229,"amplitude":0.047619,"askPrice":0.81,"askSize":579000,"bidPrice":0.8,"bidSize":913000,"shortable":3,"etf":0,"ttmEps":-0.21357985624834094,"exchange":"SEHK","tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1721698200000},"adr":0,"listingDate":1612368000000,"adjPreClose":0.84,"openAndCloseTimeList":[[1721611800000,1721620800000],[1721624400000,1721635200000]],"volumeRatio":3.247208,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02160","defaultTab":"news","newsList":[{"id":"2453855057","title":"心通医疗-B:与科威医疗达成多项合作 1000 万贷款","url":"https://stock-news.laohu8.com/highlight/detail?id=2453855057","media":"和讯网","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2453855057?lang=zh_cn&edition=full","pubTime":"2024-07-22 08:21","pubTimestamp":1721607705,"startTime":"0","endTime":"0","summary":"【心通医疗-B 有新动作!】2024 年 7 月 19 日,心通医疗-B 公布,上海微创心通与科威医疗订立 2024 年科威分销框架协议,科威医疗同意向上海微创心通授出在中国分销分销产品的独家权利,期限从 2024 年 7 月 19 日起至 2025 年 12 月 31 日止。同日,上海微创心通与科威医疗订立科威贷款协议,上海微创心通授出本金额为人民币 1000 万元的贷款融资,利率等于科威贷款协议日期的一年期 LPR。贷款融资由科威医疗以上海微创心通为受益人作出的以其若干设备及设施作为抵押品的保证作担保。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407220949109edd597d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407220949109edd597d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1100","BK1574","BK1583","02160"],"gpt_icon":0},{"id":"2453011682","title":"心通医疗-B:上海微创心通与科威医疗订立2024年科威分销框架协议","url":"https://stock-news.laohu8.com/highlight/detail?id=2453011682","media":"新浪港股","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2453011682?lang=zh_cn&edition=full","pubTime":"2024-07-22 07:54","pubTimestamp":1721606040,"startTime":"0","endTime":"0","summary":" 心通医疗-B公布,于2024年7月19日,上海微创心通与科威医疗订立2024年科威分销框架协议,据此,科威医疗同意向上海微创心通授出在中国分销分销产品的独家权利,期限由2024年7月19日起至2025年12月31日止。贷款融资将由科威医疗以上海微创心通为受益人作出的以科威医疗的若干设备及设施作为抵押品的保证作担保。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-07-22/doc-inceyanm4951668.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-07-22/doc-inceyanm4951668.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1100","BK1574","BK1583","159891","02160"],"gpt_icon":0},{"id":"2452477127","title":"心通医疗-B(02160):上海微创心通与科威医疗订立2024年科威分销框架协议","url":"https://stock-news.laohu8.com/highlight/detail?id=2452477127","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452477127?lang=zh_cn&edition=full","pubTime":"2024-07-19 22:55","pubTimestamp":1721400946,"startTime":"0","endTime":"0","summary":"于2024年7月19日,上海微创心通与科威医疗订立科威贷款协议,据此,上海微创心通同意向科威医疗授出本金额为人民币1000万元的贷款融资,利率相等于科威贷款协议日期的一年期 LPR。贷款融资将由科威医疗以上海微创心通为受益人作出的以科威医疗的若干设备及设施作为抵押品的保证作担保。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1153535.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1574","159891","BK1583","02160","BK1100"],"gpt_icon":0},{"id":"2452801414","title":"心通医疗-B(02160)下跌5.68%,报0.83元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2452801414","media":"金融界","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452801414?lang=zh_cn&edition=full","pubTime":"2024-07-19 14:14","pubTimestamp":1721369691,"startTime":"0","endTime":"0","summary":"7月19日,心通医疗-B(02160)盘中下跌5.68%,截至14:14,报0.83元/股,成交297.42万元。微创心通医疗科技有限公司是一家专注于心脏瓣膜疾病领域的创新的经导管及手术解决方案的研发和商业化的医疗器械企业。公司自主研发的第一代和第二代经导管主动脉瓣植入产品VitaFlow和VitaFlow Liberty已分别于2019年和2021年获得国家药监局审批上市,并已在中国进行商业化,同时第二代产品VitaFlow Liberty正在欧洲进行临床试验。截至2023年年报,心通医疗-B营业总收入3.36亿元、净利润-4.72亿元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/07/19141441668848.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["02160","BK1583","BK1100","BK1574"],"gpt_icon":0},{"id":"2452141457","title":"心通医疗-B盘中异动 股价大跌5.68%","url":"https://stock-news.laohu8.com/highlight/detail?id=2452141457","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452141457?lang=zh_cn&edition=full","pubTime":"2024-07-19 14:14","pubTimestamp":1721369686,"startTime":"0","endTime":"0","summary":"2024年07月19日下午盘14时14分,心通医疗-B股票出现异动,股价快速跳水5.68%。截至发稿,该股报0.830港元/股,成交量350.3万股,换手率0.15%,振幅5.68%。心通医疗-B股票所在的医疗设备及用品行业中,整体跌幅为0.17%。其相关个股中,普华和顺、加和国际控股、现代牙科涨幅较大,振幅较大的相关个股有紫元元、百心安-B、微泰医疗-B,振幅分别为10.71%、9.52%、6.93%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407191414469681e667&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407191414469681e667&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02160","BK1583","BK1100","BK1574"],"gpt_icon":0},{"id":"2452147634","title":"心通医疗-B(02160)股价下跌5.682%,现价港币$0.83","url":"https://stock-news.laohu8.com/highlight/detail?id=2452147634","media":"阿斯达克财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452147634?lang=zh_cn&edition=full","pubTime":"2024-07-19 14:14","pubTimestamp":1721369640,"startTime":"0","endTime":"0","summary":"[下跌股]心通医疗-B(02160) 股价在下午02:14比前收市价下跌5.682%,现股价为港币$0.83。至目前为止,今日最高价为$0.88,而最低价为$0.83。总成交量为350.3万股,总成交金额为港币$297.415万。","market":"hk","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180126135510179_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180126135510179_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD2407193652/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1100","BK1574","BK1583","02160"],"gpt_icon":0},{"id":"2450380647","title":"心通医疗-B盘中异动 股价大涨5.95%报0.890港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2450380647","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450380647?lang=zh_cn&edition=full","pubTime":"2024-07-11 15:55","pubTimestamp":1720684543,"startTime":"0","endTime":"0","summary":"2024年07月11日临近收盘15时55分,心通医疗-B股票出现异动,股价快速上涨5.95%。截至发稿,该股报0.890港元/股,成交量289.2万股,换手率0.12%,振幅7.14%。资金方面,该股资金流入168.733万港元,流出54.407万港元。其相关个股中,加和国际控股、微创脑科学、沛嘉医疗-B涨幅较大,振幅较大的相关个股有加和国际控股、紫元元、微创脑科学,振幅分别为21.31%、13.61%、10.11%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240711155543941f6393&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240711155543941f6393&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","BK1574","02160","BK1100"],"gpt_icon":0},{"id":"2450387044","title":"心通医疗-B(02160)股价上升5.952%,现价港币$0.89","url":"https://stock-news.laohu8.com/highlight/detail?id=2450387044","media":"阿斯达克财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450387044?lang=zh_cn&edition=full","pubTime":"2024-07-11 15:55","pubTimestamp":1720684500,"startTime":"0","endTime":"0","summary":"[上升股]心通医疗-B(02160) 股价在下午03:55比前收市价上升5.952%,现股价为港币$0.89。至目前为止,今日最高价为$0.89,而最低价为$0.83。总成交量为289.2万股,总成交金额为港币$250.656万。","market":"hk","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20190515141041255_s.png","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20190515141041255_s.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2407114569/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1100","BK1583","02160","BK1574"],"gpt_icon":0},{"id":"2449725591","title":"心通医疗-B07月08日主力资金流出67万元 连续3日减仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2449725591","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2449725591?lang=zh_cn&edition=full","pubTime":"2024-07-08 16:16","pubTimestamp":1720426560,"startTime":"0","endTime":"0","summary":"07月08日, 心通医疗-B股价跌4.60%,报收0.83元,成交金额189万元,换手率0.09%,振幅4.60%,量比0.55。心通医疗-B今日主力资金净流出67万元,连续3日净流出,上一交易日主力净流出59万元,今日环比增加13.56%。近一年数据显示,该股主力连续3日净流出后,次日下跌概率为50.00%,平均跌幅为3.36%。该股近5个交易日上涨1.20%,主力资金累计净流出118万元;近20日主力资金累计净流出624万元,其中净流出天数为13日。该股主力净额占比0.03%,港股市场排名2511/2643。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407081616449f1d5ff4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407081616449f1d5ff4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","BK1100","02160","BK1583"],"gpt_icon":0},{"id":"2449538253","title":"心通医疗-B07月05日遭主力抛售59万元 环比增加195.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2449538253","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2449538253?lang=zh_cn&edition=full","pubTime":"2024-07-05 16:17","pubTimestamp":1720167426,"startTime":"0","endTime":"0","summary":"07月05日, 心通医疗-B股价涨3.57%,报收0.87元,成交金额453万元,换手率0.21%,振幅5.95%,量比1.34。心通医疗-B今日主力资金净流出59万元,上一交易日主力净流出20万元,今日环比增加195.00%。该股近5个交易日上涨4.82%,主力资金累计净流出122万元;近20日主力资金累计净流出558万元,其中净流出天数为12日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240705161751957b23ac&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240705161751957b23ac&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1100","BK1583","02160","BK1574"],"gpt_icon":0},{"id":"2449318022","title":"心通医疗预计今年上半年收入同比增长22%-28%","url":"https://stock-news.laohu8.com/highlight/detail?id=2449318022","media":"新京报网","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2449318022?lang=zh_cn&edition=full","pubTime":"2024-07-05 14:39","pubTimestamp":1720161540,"startTime":"0","endTime":"0","summary":"新京报讯 7月5日,心通医疗发布2024年中期业绩预告,报告期内预计收入2.15亿元-2.25亿元,同比增长22%至28%。报告期内,公司旗下TAVI产品新增进入国内50家医院至合计超过600家。今年上半年,VitaFlow Liberty经导管主动脉瓣膜及输送系统和Alwide Plus球囊扩张导管在俄罗斯和智利等国的商业化带来的海外收入快速增长,VitaFlow Liberty获得CE证书,在部分欧洲国家实现首次销售和植入。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240705143934aef81705&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240705143934aef81705&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","BK1100","02160","BK1583"],"gpt_icon":0},{"id":"2449846242","title":"港股异动 | 发盈喜,心通医疗-B一度涨超8% 日前曾创新低","url":"https://stock-news.laohu8.com/highlight/detail?id=2449846242","media":"格隆汇资讯","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2449846242?lang=zh_cn&edition=full","pubTime":"2024-07-05 11:40","pubTimestamp":1720150811,"startTime":"0","endTime":"0","summary":"日前曾创历史新低的心通医疗-B(2160.HK)盘初一度涨超8%,现报0.88港元,总市值20.8亿港元。消息上,公司预期上半年收入将在2.15亿元至2.25亿元,较上年同期增长约22%至28%。附属上海佐心自主研发的AnchorMan在内地正式开启商业化进程,为集团贡献增量收入等。于报告期内,集团的TAVI产品新增进入中国50家医院至合计超过600家。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407051140219f07a8c4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407051140219f07a8c4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","07226","BK1583","HSCEI","02160","BK1100","HSTECH"],"gpt_icon":0},{"id":"2449400901","title":"心通医疗-B早盘一度涨超8% 预计上半年收入同比增长逾22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2449400901","media":"新浪港股","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2449400901?lang=zh_cn&edition=full","pubTime":"2024-07-05 09:50","pubTimestamp":1720144250,"startTime":"0","endTime":"0","summary":"心通医疗-B(02160)早盘一度涨超8%,现涨幅收窄至上涨4.76%,报0.88港元,成交额240.49万港元。\n 心通医疗发布公告称,集团预期截至2024年6月30日止6个月收入将在人民币2.15亿元至人民币2.25亿元,同比增长约22%至28%。\n\n\n海量资讯、精准解读,尽在新浪财经APP","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"highlight_sina","url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2024-07-05/doc-incazvwu2218215.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}","selectors":".art_box, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action, .fl_popup, .weibo_info","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2024-07-05/doc-incazvwu2218215.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_sina","symbols":["BK1100","BK1583","02160","BK1574"],"gpt_icon":0},{"id":"2449407578","title":"港股异动 | 心通医疗-B(02160)一度涨超8% 预计上半年收入同比增长逾22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2449407578","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2449407578?lang=zh_cn&edition=full","pubTime":"2024-07-05 09:32","pubTimestamp":1720143132,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,心通医疗-B(02160)一度涨超8%,截至发稿,涨4.76%,报0.88港元,成交额163.76万港元。消息面上,心通医疗发布公告称,集团预期截至2024年6月30日止6个月收入将在人民币2.15亿元至人民币2.25亿元,同比增长约22%至28%。主要因经导管主动脉瓣植入术产品在内地的入院持续进展推动产品植入量和配件产品使用量增长,带来收入增加;附属上海佐心自主研发的AnchorMan在内地正式开启商业化进程,为集团贡献增量收入等。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1145957.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["YANG","BK1100","HSTECH","BK1583","BK1574","HSCEI","07226","02160"],"gpt_icon":0},{"id":"2449407669","title":"心通医疗-B盘中异动 股价大涨5.95%","url":"https://stock-news.laohu8.com/highlight/detail?id=2449407669","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2449407669?lang=zh_cn&edition=full","pubTime":"2024-07-05 09:30","pubTimestamp":1720143006,"startTime":"0","endTime":"0","summary":"2024年07月05日早盘09时30分,心通医疗-B股票出现异动,股价大幅拉升5.95%。截至发稿,该股报0.890港元/股,成交量57.6万股,换手率0.02%,振幅3.57%。心通医疗-B股票所在的医疗设备及用品行业中,整体涨幅为0.05%。其相关个股中,微创机器人-B、心通医疗-B、加和国际控股涨幅较大,振幅较大的相关个股有心通医疗-B、智云健康、微创机器人-B,振幅分别为1.19%、1.11%、1.11%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240705093006af90a41b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240705093006af90a41b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1100","BK1574","02160","BK1583"],"gpt_icon":0},{"id":"2449940122","title":"【港股通】心通医疗(02160)料中期收入同比增长约22%至28%","url":"https://stock-news.laohu8.com/highlight/detail?id=2449940122","media":"金吾财讯","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2449940122?lang=zh_cn&edition=full","pubTime":"2024-07-05 08:48","pubTimestamp":1720140508,"startTime":"0","endTime":"0","summary":"金吾财讯 | 心通医疗 公布,预期截至2024年6月30日止六个月收入将在人民币2.15亿元至人民币2.25亿元,较上年同期增长约22%至28%。于报告期内,集团的TAVI产品新增进入中国50家医院至合计超过600家;附属公司上海佐心医疗科技有限公司自主研发的AnchorMan左心耳封堵器系统及其导引系统于报告期内在中国正式开启商业化进程,为集团贡献增量收入。","market":"fut","thumbnail":"https://static.szfiu.com/news/20210810/OWRlOWUwM2UzYzc0YWVmOThhNzQ1ZDFlMmFkZGIzYjY4MTQyOTUwNzU2MTA=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210810/OWRlOWUwM2UzYzc0YWVmOThhNzQ1ZDFlMmFkZGIzYjY4MTQyOTUwNzU2MTA=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"1939815","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["YANG","BK1100","HSTECH","BK1583","BK1574","HSCEI","07226","02160"],"gpt_icon":0},{"id":"2449240391","title":"心通医疗-B预计中期收入约2.15亿至2.25亿元 同比增长约22%至28%","url":"https://stock-news.laohu8.com/highlight/detail?id=2449240391","media":"新浪港股","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2449240391?lang=zh_cn&edition=full","pubTime":"2024-07-05 07:19","pubTimestamp":1720135149,"startTime":"0","endTime":"0","summary":"心通医疗-B(02160)发布公告,集团预期截至2024年6月30日止6个月收入将在人民币2.15亿元至人民币2.25亿元,较上年同期增长约22%至28%。\n\n\n海量资讯、精准解读,尽在新浪财经APP","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"highlight_sina","url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-07-05/doc-incazrqu6787868.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}","selectors":".art_box, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action, .fl_popup, .weibo_info","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-07-05/doc-incazrqu6787868.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_sina","symbols":["02160","BK1100","BK1574","BK1583"],"gpt_icon":0},{"id":"2449420276","title":"心通医疗(02160.HK)预告上半年收入增加22%-28%","url":"https://stock-news.laohu8.com/highlight/detail?id=2449420276","media":"阿斯达克财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2449420276?lang=zh_cn&edition=full","pubTime":"2024-07-05 01:15","pubTimestamp":1720113300,"startTime":"0","endTime":"0","summary":"心通医疗-B公布,预计6月止六个月收入介乎2.15亿至2.25亿人民币,按年增加22%-28%。期内,集团严格执行成本管控措施,提升运营效率,致力在保持收入稳步增长的前提下尽快实现盈亏平衡。沽空资料截至 2024-07-04 16:25。)过往派息公布日期派息事项派息内容2024/03/27末期业绩无派息2023/08/29中期业绩无派息2023/03/29末期业绩无派息 2022/08/29中期业绩无派息 AASTOCKS新闻","market":"sh","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20220906143936150_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20220906143936150_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1361472/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["02160","BK1574","BK1583","BK1100"],"gpt_icon":0},{"id":"2449403895","title":"心通医疗-B:上半年收入预计增长22%至28%,达215至225百万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2449403895","media":"和讯网","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2449403895?lang=zh_cn&edition=full","pubTime":"2024-07-04 22:36","pubTimestamp":1720103805,"startTime":"0","endTime":"0","summary":"快讯正文心通医疗-B初步评估显示,截至2024年6月30日止六个月,公司收入预计在人民币215百万元至225百万元之间,同比增长约22%至28%。此外,附属公司上海佐心医疗科技有限公司的AnchorMan左心耳封堵器系统及其导引系统在中国正式商业化,已完成近20个省的挂网和10余个省的挂网申报,积极推进入院和植入。同时,海外战略布局也在全面推进,AlwidePlus和AnchorMan的CE注册取得关键进展。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407050655359f062ac8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407050655359f062ac8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1100","BK1583","02160","BK1574"],"gpt_icon":0},{"id":"2449476969","title":"心通医疗-B:预计2024年上半年收入达215百万元至225百万元人民币,同比增长22%至28%","url":"https://stock-news.laohu8.com/highlight/detail?id=2449476969","media":"金融界港股","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2449476969?lang=zh_cn&edition=full","pubTime":"2024-07-04 22:09","pubTimestamp":1720102198,"startTime":"0","endTime":"0","summary":"金融界7月4日消息,心通医疗-B近期发布公告,据对2024年上半年未经审核的综合管理账目及现有的数据初步估计,该公司预计收入将在人民币215百万元至225百万元,同比增长约22%至28%。收入增长主要归因于其经导管主动脉瓣植入术(TAVI)产品在中国的市场进展,以及附属公司上海佐心医疗科技有限公司自主研发的AnchorMan®左心耳封堵器系统在中国的商业化进程等因素。此外,公司也致力于执行资源聚焦战略与降低成本,以提升运营效率。\n\n\r\n 责任编辑:安东","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/07/04220941385569.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["02160","BK1583","BK1100","BK1574"],"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":-0.0805},{"period":"1month","weight":-0.0476},{"period":"3month","weight":-0.1753},{"period":"6month","weight":-0.3388},{"period":"1year","weight":-0.6244},{"period":"ytd","weight":-0.5062}],"compareEarnings":[{"period":"1week","weight":-0.0211},{"period":"1month","weight":-0.0218},{"period":"3month","weight":0.048},{"period":"6month","weight":0.1092},{"period":"1year","weight":-0.0755},{"period":"ytd","weight":0.0345}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"微创心通医疗科技有限公司是一家主要从事医疗器械行业的中国投资控股公司。该公司主要从事心脏瓣膜疾病领域经导管及手术解决方案的研发和商业化。该公司主要产品包括第一代经导管主动脉瓣植入(TAVI)产 品“VitaFlow”和第二代TAVI产品“VitaFlow II”。该公司主要于国内市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":0.011377},{"month":2,"riseRate":0,"avgChangeRate":-0.108287},{"month":3,"riseRate":0,"avgChangeRate":-0.164923},{"month":4,"riseRate":0.25,"avgChangeRate":0.055893},{"month":5,"riseRate":0.25,"avgChangeRate":-0.107084},{"month":6,"riseRate":0.5,"avgChangeRate":0.027456},{"month":7,"riseRate":0.25,"avgChangeRate":-0.061596},{"month":8,"riseRate":0.333333,"avgChangeRate":-0.11284},{"month":9,"riseRate":0,"avgChangeRate":-0.184101},{"month":10,"riseRate":0.666667,"avgChangeRate":0.017935},{"month":11,"riseRate":0.333333,"avgChangeRate":-0.041509},{"month":12,"riseRate":0.333333,"avgChangeRate":-0.071723}],"exchange":"SEHK","name":"心通医疗-B","nameEN":"CARDIOFLOW-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"心通医疗-B(02160)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供心通医疗-B(02160)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"心通医疗-B,02160,心通医疗-B股票,心通医疗-B股票老虎,心通医疗-B股票老虎国际,心通医疗-B行情,心通医疗-B股票行情,心通医疗-B股价,心通医疗-B股市,心通医疗-B股票价格,心通医疗-B股票交易,心通医疗-B股票购买,心通医疗-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"心通医疗-B(02160)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供心通医疗-B(02160)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}